Carl Zeiss Medit-Unspon ADRCZMWY
13F holders, Q2 2025 (June 30)1holders
0new positions
0sold out
$67.36avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Carl Zeiss Medit-Unspon ADR (CZMWY) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holder was Rhumbline Advisers ($943).
- Company
- Carl Zeiss Medit-Unspon ADR
- CUSIP
- 14218T105
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Rhumbline Advisers | 0.00% | No change | 14 | $943 |
"% of holder's portfolio" is CZMWY's weight in each manager's 13F, not the share of Carl Zeiss Medit-Unspon ADR the manager owns.